MWNA
INSM icon

Marshall Wace North America’s Insmed INSM Stock Holding History

Marshall Wace North America’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,617
Closed -$533K – 1427
2020
Q3 		$533K Buy
+16,617
New +$478K ﹤0.01% 952
2020
Q1 		– Sell
-9,539
Closed -$228K – 1404
2019
Q4 		$228K Sell
9,539
-29,176
-75% -$593K ﹤0.01% 945
2019
Q3 		$683K Buy
+38,715
New +$748K ﹤0.01% 760
2013
Q4 		– Sell
-22,043
Closed -$344K – 765
2013
Q3 		$344K Buy
+22,043
New +$280K 0.01% 498

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace North America's INSM Position: Q4 2020 in Review

Marshall Wace North America sold out of Insmed (INSM) in Q4 2020, closing a stake of 16,617 shares — an estimated $533K sold.

Marshall Wace North America first reported a position in INSM in Q3 2013 and held it in 4 quarters. The position peaked at $683K in Q3 2019. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

  • Marshall Wace North America reported no remaining Insmed position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 16,617 Insmed shares in Q4 2020, an estimated $533K.
  • Marshall Wace North America first reported a position in Insmed in Q3 2013 and held it in 4 quarters.
  • Marshall Wace North America's Insmed position peaked at $683K in Q3 2019.
  • 206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.